Pharming Group N.V (PHAR) EBIAT: 2020-2025
Historic EBIAT for Pharming Group N.V (PHAR) over the last 4 years, with Sep 2025 value amounting to $90.2 million.
- Pharming Group N.V's EBIAT rose 8824.95% to $90.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $81.7 million, marking a year-over-year increase of 397.78%. This contributed to the annual value of -$11.8 million for FY2024, which is 12.26% down from last year.
- According to the latest figures from Q3 2025, Pharming Group N.V's EBIAT is $90.2 million, which was up 972.66% from -$10.3 million recorded in Q2 2025.
- In the past 5 years, Pharming Group N.V's EBIAT ranged from a high of $90.2 million in Q3 2025 and a low of -$14.6 million during Q4 2022.
- In the last 3 years, Pharming Group N.V's EBIAT had a median value of -$5.7 million in 2024 and averaged $3.6 million.
- Per our database at Business Quant, Pharming Group N.V's EBIAT spiked by 40,507.77% in 2022 and then crashed by 1,879.82% in 2023.
- Quarterly analysis of 5 years shows Pharming Group N.V's EBIAT stood at $16.0 million in 2021, then slumped by 191.54% to -$14.6 million in 2022, then surged by 98.02% to -$289,000 in 2023, then soared by 1,089.27% to $2.9 million in 2024, then spiked by 8,824.95% to $90.2 million in 2025.
- Its last three reported values are $90.2 million in Q3 2025, -$10.3 million for Q2 2025, and $2.9 million during Q4 2024.